FindTrial
Sign In

Comparison of two injectable anesthetic drugs for the benefits of patients in modified electroconvulsive therapy(ECT)

Comparison of propofol and ketofol(combination of ketamine and propofol)for modified electroconvulsive therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012341
Enrollment
60
Registered
2018-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA GRADE I AND II Health Condition 2: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy

Interventions

Intervention1: â??COMPARISON OF PROPOFOL AND KETOFOL (COMBINATION OF KETAMINE AND PROPOFOL) FOR MODIFIED ELECTROCONVULSIVE THERAPYâ??: â??COMPARISON OF PROPOFOL AND KETOFOL (COMBINATION OF KETAMINE AN

Sponsors

Girish Kumar Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 18-65 years of either sex undergoing modified electroconvulsive therapy(ECT) 2.ASA grade I & II

Exclusion criteria

Exclusion criteria: 1.Refusal of patient or relatives. 2.Allergy to trial drugs. 3.Major illness like T.B., asthma, neuromuscular disorders, respiratory disorders, hypertension, epilepsy, cardiovascular diseases, diabetes, history of MI in last six months. • Patient on drugs which may alter the hemodynamic parameters.

Design outcomes

Primary

MeasureTime frame
In Patients undergoing modified ECT, ketofol provides lesser induction time, better hemodynamic stability, longer mean seizure duration, earlier and smooth recovery as compared to propofol. further research with ketofol in modified ECT is warrantedTimepoint: september 2016 to september 2017—

Secondary

MeasureTime frame
Ketofol is better inducing agent then propofol in modified ECTTimepoint: One Year—

Countries

India

Contacts

Public ContactGirish Kumar Singh

King Georges Medical University Lucknow

dineshkgmu@yahoo.com9415022330

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026